Drug Trial Radar · NCT03888053
BB-101 for Treatment of Diabetic Lower Leg and Foot Ulcers
Last checked: Nov 19, 2026Latest source record: Apr 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
14
Actual
Start
Mar 28, 2018
Primary completion
Dec 1, 2021
Study completion Dec 31, 2023
Sponsor
- Lead sponsor
- Blue Blood Biotech Corp.Industry
- Sponsor type
- Industry
- First posted
- Mar 25, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, placebo-controlled, sequential dose escalation study in diabetic subjects with a diabetic lower leg or foot ulcer. All subjects will receive standard-of-care ulcer treatment from screening through the last study visit.
Conditions
- Diabetic Foot Ulcer
Interventions
BB-101Biological
Within each cohort, 8 subjects will be randomized to receive BB-101 and 4 subjects to receive placebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and severity of local reactionsTime frame: 6 weeks
- Incidence and severity of adverse eventsTime frame: 6 weeks
- Incidence of clinical laboratory abnormalitiesTime frame: 6 weeks
- Change from baseline in ECGTime frame: 6 weeks
- Change from baseline in blood pressureTime frame: 6 weeks
- Change from baseline in heart rateTime frame: 6 weeks
- Change from baseline in body temperatureTime frame: 6 weeks
- Presence of anti-BB-101 antibodiesTime frame: 6 weeks
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
E-DA Hospital
Kaohsiung City, Taiwan
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
Shuangho Hospital
New Taipei City, Taiwan
National Cheng Kung University Hospital
Tainan, Taiwan
Shin Kong Wu Ho-Su Memorial Hospital
Taipei, Taiwan
Tri-Service General Hospital
Taipei, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.